Exact Mass: 691.3453

Exact Mass Matches: 691.3453

Found 61 metabolites which its exact mass value is equals to given mass value 691.3453, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

17-(4-hydroxyphenyl)heptadecanoyl-AMP

17-(4-Hydroxyphenyl)heptadecanoyl adenylate

C33H50N5O9P (691.3346)


   

N,N-Diallyl-tyrosyl-aminoisobutyryl-aminoisobutyryl-phenylalanyl-leucine

2-({2-[(2-{[2-({2-[bis(prop-2-en-1-yl)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-1-hydroxy-2-methylpropylidene]amino}-1-hydroxy-2-methylpropylidene)amino]-1-hydroxy-3-phenylpropylidene}amino)-4-methylpentanoate

C38H53N5O7 (691.3945)


   

Noa-Asn-Apns-Dmt-NH-tBu

N-[4-[4-(tert-butylcarbamoyl)-5,5-dimethyl-1,3-thiazolidin-3-yl]-3-hydroxy-4-oxo-1-phenylbutan-2-yl]-2-[(2-naphthalen-1-yloxyacetyl)amino]butanediamide

C36H45N5O7S (691.304)


   
   
   
   

3beta-O-propionyl-5alpha-O-benzoyl-7beta-O-acetyl-17-O-nicotinoylpremyrsinol|euphorbialoid A

3beta-O-propionyl-5alpha-O-benzoyl-7beta-O-acetyl-17-O-nicotinoylpremyrsinol|euphorbialoid A

C38H45NO11 (691.2992)


   

FEHFL

Phe-Glu-His-Phe-Leu

C35H45N7O8 (691.3329)


   
   
   

OKODiA-PS

1-(9Z-octadecenoyl)-2-(5-oxo-7-carboxy-6E-heptenoyl)-sn-glycero-3-phosphoserine

C32H54NO13P (691.3333)


   

Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)lead(ii)

Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)lead(ii)

C33H60LaO6 (691.3453)


   

(S)-METHYL 3-METHYL-2-(N-((2-(1-TRITYL-1H-TETRAZOL-5-YL)-[1,1-BIPHENYL]-4-YL)METHYL)PENTANAMIDO)BUTANOATE

(S)-METHYL 3-METHYL-2-(N-((2-(1-TRITYL-1H-TETRAZOL-5-YL)-[1,1-BIPHENYL]-4-YL)METHYL)PENTANAMIDO)BUTANOATE

C44H45N5O3 (691.3522)


   

Neodymium,tris(2,2,6,6-tetramethyl-3,5-heptanedionato-kO3,kO5)-, (OC-6-11)-

Neodymium,tris(2,2,6,6-tetramethyl-3,5-heptanedionato-kO3,kO5)-, (OC-6-11)-

C33H57NdO6 (691.3232)


   

(3S)-3-methylsulfanyl-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxypyridin-3-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide

(3S)-3-methylsulfanyl-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxypyridin-3-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide

C37H41N9O3S (691.3053)


MK-8353 (SCH900353) is a potent, selective and orally available ERK1/2 inhibitor, with IC50s of 23.0 nM and 8.8 nM, respectively; MK-8353 has antitumor activity.

   

[(4Z,6R,7R,8S,10E,12E,14E,16R)-6-hydroxy-16-methoxy-5,7-dimethyl-18,24-dioxo-22-thia-19,25-diazatricyclo[18.7.1.021,26]octacosa-1(28),4,10,12,14,20,26-heptaen-8-yl] (2R)-2-(cyclohexene-1-carbonylamino)propanoate

[(4Z,6R,7R,8S,10E,12E,14E,16R)-6-hydroxy-16-methoxy-5,7-dimethyl-18,24-dioxo-22-thia-19,25-diazatricyclo[18.7.1.021,26]octacosa-1(28),4,10,12,14,20,26-heptaen-8-yl] (2R)-2-(cyclohexene-1-carbonylamino)propanoate

C38H49N3O7S (691.3291)


   

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3,24-dioxo-22-thia-2,25-diazatricyclo[18.7.1.021,26]octacosa-1(28),6,8,10,16,20,26-heptaen-13-yl] (2R)-2-(cyclohexene-1-carbonylamino)propanoate

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3,24-dioxo-22-thia-2,25-diazatricyclo[18.7.1.021,26]octacosa-1(28),6,8,10,16,20,26-heptaen-13-yl] (2R)-2-(cyclohexene-1-carbonylamino)propanoate

C38H49N3O7S (691.3291)


   
   

3-cyclohexyl-1-[[(3S,9S,10S)-16-[(3,5-dimethyl-4-isoxazolyl)sulfonylamino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea

3-cyclohexyl-1-[[(3S,9S,10S)-16-[(3,5-dimethyl-4-isoxazolyl)sulfonylamino]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methylurea

C34H53N5O8S (691.3615)


   
   

SHexCer 15:3;2O/12:1;O

SHexCer 15:3;2O/12:1;O

C33H57NO12S (691.3601)


   

PI-Cer 15:3;2O/12:1;O

PI-Cer 15:3;2O/12:1;O

C33H58NO12P (691.3696)


   
   

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C36H54NO10P (691.3485)


   
   
   
   
   
   
   
   
   
   

PS P-16:0/11:3;O3

PS P-16:0/11:3;O3

C33H58NO12P (691.3696)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

ST 27:6;O8;HexNAc

ST 27:6;O8;HexNAc

C35H49NO13 (691.3204)


   

ST 28:5;O7;HexNAc

ST 28:5;O7;HexNAc

C36H53NO12 (691.3568)


   

ST 29:4;O6;HexNAc

ST 29:4;O6;HexNAc

C37H57NO11 (691.3931)


   

[(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-15-(acetyloxy)-2-(benzoyloxy)-7,9-dihydroxy-5,9,12,12-tetramethyl-8-oxo-4-(propanoyloxy)tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

[(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-15-(acetyloxy)-2-(benzoyloxy)-7,9-dihydroxy-5,9,12,12-tetramethyl-8-oxo-4-(propanoyloxy)tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

C38H45NO11 (691.2992)


   

(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl 4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-bis(3-methylbut-2-en-1-yl)benzoate

(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl 4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-bis(3-methylbut-2-en-1-yl)benzoate

C36H53NO12 (691.3568)


   

5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C36H45N5O7S (691.304)


   

2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-9,19,25-trien-13-yl acetate

2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-9,19,25-trien-13-yl acetate

C36H53NO12 (691.3568)


   

(2s,5s,8s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

(2s,5s,8s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C36H45N5O7S (691.304)


   

hexahydro-1h-pyrrolizin-1-ylmethyl 4-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-3,5-bis(3-methylbut-2-en-1-yl)benzoate

hexahydro-1h-pyrrolizin-1-ylmethyl 4-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-3,5-bis(3-methylbut-2-en-1-yl)benzoate

C36H53NO12 (691.3568)


   

6-[(4,6-dimethyloctanoyl)oxy]-4,7-dihydroxy-1-(3-{[(1-hydroxyethylidene)amino]methyl}-5-methyl-6-phenylhex-3-en-1-yl)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

6-[(4,6-dimethyloctanoyl)oxy]-4,7-dihydroxy-1-(3-{[(1-hydroxyethylidene)amino]methyl}-5-methyl-6-phenylhex-3-en-1-yl)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid

C35H49NO13 (691.3204)


   

(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl 4-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-bis(3-methylbut-2-en-1-yl)benzoate

(1s,7ar)-hexahydro-1h-pyrrolizin-1-ylmethyl 4-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-bis(3-methylbut-2-en-1-yl)benzoate

C36H53NO12 (691.3568)


   

(2s,5s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

(2s,5s,11s,14r,15r)-5-benzyl-4,17-dihydroxy-8-[(4-hydroxyphenyl)methyl]-2,6,9,11,14-pentamethyl-15-propyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C36H45N5O7S (691.304)


   

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,18-dihydroxy-5,9-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,18-dihydroxy-5,9-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C33H57NO14 (691.3779)


   

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,22r)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-9,19,25-trien-13-yl acetate

(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,22r)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,29,30-trioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-9,19,25-trien-13-yl acetate

C36H53NO12 (691.3568)